Select Language:
China’s vaccine exports increased by more than 50% last year, driven by a surge in shipments despite falling prices. The country’s vaccine exports reached $324 million in 2025, a 53% increase from the previous year, according to data released by the China Chamber of Commerce for Import and Export of Medicines and Health Products.
The growth in export value was primarily fueled by a 131% jump in the volume of vaccines shipped, contrasting with the previous year when higher prices contributed more to the increase. For instance, in 2024, the export value of human vaccines grew by 9.4%, partly due to a 34% rise in the average unit price compared to 2019.
Last year, China exported human vaccines to 85 markets worldwide, with the top 10 markets representing 70% of total export value. Shipments to Pakistan rose by 131%, exports to Brazil increased by 120%, and exports to Myanmar nearly multiplied by thirty.
As competition intensifies within the Chinese vaccine market, more domestic manufacturers are expanding into international markets. Many are leveraging opportunities through cooperation with Belt and Road Initiative countries to strengthen their presence in developing nations and regions abroad.
Kangtai Biological Products projects its overseas revenue skyrocketed by 859% to CNY 98.8 million (approximately USD 14.2 million) in 2025, up from 2024, while overall revenue saw only slight growth, the company reported yesterday.
Similarly, Wantai Biological Pharmacy stated that to offset negative impacts on its bivalent human papillomavirus (HPV) vaccine segment, it actively explored international markets and accelerated research, development, and launch of innovative products, which yielded notable results. The company’s foreign income from its HPV vaccine saw exponential growth in 2025.
Meanwhile, Walvax Biotechnology anticipates that its decline in revenue from the Chinese market narrowed last year. The company’s overseas income remained steady with an approximate 35% increase, according to a report from January 28.
ChatGPT
Perplexity
Gemini AI
Grok AI
